Less equity than 89% of companies in human health. Sector median €125,088 · 21,349 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as Dr. Noor De Wilde has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Micro
under 2 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for Dr. Noor De Wilde. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered office moved from Mechelen to Kessel-Lo
The registered office moved from Lange Zandstraat 34, 2800 Mechelen to Rietgors 15, 3010 Kessel-Lo · Hidden nameVisible after signing in acts as permanent representative · General meeting of 09-07-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1026808940
Incorporation
Founding capital of €1,200, 120 shares · Founded by Name after signing inVisible after signing in · Name hiddenVisible after signing in appointed as director · published on 27-08-2025 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Dr. Noor De Wilde: general medical practice (NACE 86210). They are comparable in size and age: total assets between €17,000 and €24,200, founded in 2025.
Dr. Noor De Wilde has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,910 and a net result of €7,793.
Its solvency ranks better than 28% of 21,347 sector peers (NACE 86) in financial year 2025.
The company number of Dr. Noor De Wilde is 1026.808.940. The VAT number is the same number with BE in front: BE 1026.808.940.
Where is Dr. Noor De Wilde based?
The registered office is at Rietgors 15, 3010 Leuven.Company details
What does Dr. Noor De Wilde do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Noor De Wilde?
Dr. Noor De Wilde is a private limited company (BV).
When was Dr. Noor De Wilde founded?
Dr. Noor De Wilde was founded on 25-08-2025.
Is Dr. Noor De Wilde still active?
Yes, Dr. Noor De Wilde is an active enterprise in the KBO register.
What is the turnover of Dr. Noor De Wilde?
The turnover in financial year 2025 is ≈ €62,000. This figure is estimated from the gross margin of €10,042 and 52 comparable companies (NACE 86). It probably lies between €43,000 and €110,000. It is a rough estimate.Financials
Is Dr. Noor De Wilde profitable?
In financial year 2025, Dr. Noor De Wilde made a profit of €7,793.
Where can I find the annual accounts of Dr. Noor De Wilde?
Dr. Noor De Wilde filed 1 annual account with the National Bank of Belgium, for financial year 2025.